EBNA1 inhibitors for EBV-dependent cancers

DISEASE CATEGORY: Cancer

INDICATION: Nasopharyngeal cancer; lymphoma

In vitro, cell culture and mouse studies identified two prodrugs of phenylacetylenyl benzoic acid-based EBNA1

Read the full 205 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE